Phase 1 updated exploration and first expansion data for DLL3-targeted t-cell engager tarlatamab in small cell lung cancer
Authors
Borghaei, H.Paz-Ares, L.
Johnson, M.
Champiat, S.
Owonikoko, T.
Lai, V.
Boyer, M.
Hummel, H. D.
Govindan, R.
Steeghs, N.
Blackhall, Fiona H
Reguart, N.
Dowlati, A.
Zhang, Y.
Sadraei, N. H.
Goldrick, A.
Izumi, H.
Affiliation
Fox Chase Cancer Center, PhiladelphiaIssue Date
2022
Metadata
Show full item recordCitation
Borghaei H, Paz-Ares L, Johnson M, Champiat S, Owonikoko T, Lai V, et al. Phase 1 Updated Exploration and First Expansion Data for DLL3-targeted T-cell Engager Tarlatamab in Small Cell Lung Cancer. Journal of Thoracic Oncology. 2022 Sep;17(9):S33-S. PubMed PMID: WOS:000858678100053.Journal
Journal of Thoracic OncologyDOI
10.1016/j.jtho.2022.07.062Additional Links
https://dx.doi.org/10.1016/j.jtho.2022.07.062Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.jtho.2022.07.062